Alan Landay to Dose-Response Relationship, Drug
This is a "connection" page, showing publications Alan Landay has written about Dose-Response Relationship, Drug.
Connection Strength
0.083
-
Inhibition of cytokine-driven human immunodeficiency virus type 1 replication by protease inhibitor. J Infect Dis. 1997 Nov; 176(5):1175-9.
Score: 0.035
-
A randomized controlled trial of palifermin (recombinant human keratinocyte growth factor) for the treatment of inadequate CD4+ T-lymphocyte recovery in patients with HIV-1 infection on antiretroviral therapy. J Acquir Immune Defic Syndr. 2014 Aug 01; 66(4):399-406.
Score: 0.028
-
Chemokine analogues show suitable stability for development as microbicides. J Acquir Immune Defic Syndr. 2008 Dec 15; 49(5):472-6.
Score: 0.019
-
Effect of total body temperature on toxicity of 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU). Neurosurgery. 1979 Feb; 4(2):157-61.
Score: 0.002